-
Non-invasive sound therapy boosts hope for Alzheimer's treatment
07 Jan 2026 08:40 GMT
BEIJING, Jan. 7 (Xinhua) -- A team of Chinese scientists has demonstrated that simple, non-invasive sound therapy can produce significant and remarkably long-lasting biological changes in aged monkeys, offering new hope for a potential physical treatment …
-
AriBio inks ₩630 bil. deal with China’s Fosun Pharma for Alzheimer’s drug in ASEAN
07 Jan 2026 06:19 GMT
AriBio said Wednesday it has signed an exclusive licensing agreement with Fosun Pharmaceutical Group for the commercialization of AR1001, its oral Alzheimer's disease therapy, in 10 member states of the Association of Southeast Asian Nations (ASEAN).
…
-
Simple drug treatments could help older brains cope with memory decline and postoperative recovery
07 Jan 2026 01:57 GMT
Simple pharmaceutical interventions could help older brains cope with memory impairment and recovery after surgery, new studies in mice suggest.
In two studies, researchers at the University of Illinois Urbana-Champaign investigated different aspects of …
-
As Alzheimer's cases rise, MUSC pioneers new path for diagnosis and care
07 Jan 2026 00:03 GMT
(BPT) - While the country faces an ongoing physician shortage, the nationwide neurologist shortage is even greater. Given the needs of an aging population facing conditions, including Alzheimer's, dementia and other cognitive disorders, patients often …
-
Should Investors Be Concerned About This Pharmaceutical Giant's Latest Clinical Trial?
06 Jan 2026 23:48 GMT
Novo Nordisk has some good GLP-1 news, but is the company's failed Alzheimer's trial a long-term problem?
Drug companies are granted patents on new drugs they develop for a reason. The ups and downs Novo Nordisk (NVO +2.00%) experienced in 2025 …
-
Reem Hospital successfully completes its inaugural Alzheimer's disease clinical trial
06 Jan 2026 19:08 GMT
Reem Hospital today announced the successful completion and database lock for its clinical trial, the TauRx TRx-237-805 study, a major investigation into the novel therapy Hydromethylthionine Mesylate (HMTM) for the management of Alzheimer's Disease, …
-
Shankar Vedantam to Join Davos Alzheimer's Collaborative Brain House in Davos
06 Jan 2026 15:00 GMT
WASHINGTON, DC, UNITED STATES, January 6, 2026 /EINPresswire.com/ -- The Davos Alzheimer’s Collaborative (DAC), a global initiative to prevent Alzheimer’s disease and promote brain health, today announced that Shankar Vedantam, award-winning …
-
Two isoforms of a cellular energy sensor play distinct, opposing roles in Alzheimer's disease
06 Jan 2026 11:13 GMT
A comprehensive mini-review published today after peer review in Brain Medicine by Dr. Tao Ma and colleagues at Wake Forest University School of Medicine synthesizes emerging evidence that two isoforms of a critical cellular energy sensor play distinct, …
-
Simcere eyes growing pharmaceutical niche
06 Jan 2026 02:01 GMT
A Simcere employee arranges products at a production facility in Haikou, Hainan province. SUN SHIJIE/FOR CHINA DAILY
Simcere Pharmaceutical Group Ltd, a Nanjing, Jiangsu province-headquartered drugmaker, plans to expand its global presence over the …
-
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China
06 Jan 2026 01:00 GMT
About Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human …
About
© 1995-2026